Omalizumab for Chronic Urticaria in Children Less than 12 Years of Age: A Systematic Review. Miércoles 19 de junio

Omalizumab for Chronic Urticaria in Children Less than 12 Years of Age: A
Systematic Review.

Authors: 
Al-Shaikhly T1, Rosenthal JA1, Ayars AG1, Petroni DH2.
1 Department of Medicine, University of Washington, Seattle, Washington, USA.
2 Department of Medicine, University of Washington, Seattle, Washington, USA; Northwest Asthma and Allergy Center, Seattle, Washington, USA; Seattle Allergy & Asthma Research Institute, Seattle, Washington, USA. Electronic address: dpetroni@seattleallergy.org.

DOI: 10.1016/j.anai.2019.05.003

Comentarios

Entradas populares de este blog

The International EAACI/GA²LEN/EuroGuiDerm/APAAACI Guideline for the Definition, Classification, Diagnosis and Management of Urticaria

La biopsia cutánea en la urticaria crónica: cuándo realizarla, qué buscar y dónde hacerlo

Managing Food Allergy When the Patient Is Not Highly Allergic